课题基金 / 基金详情

项目摘要

项目成果

SUSAN E. BERGESON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Alcoholism, a disease of considerable morbidity, mortality and human suffering worldwide, is first and foremost characterized by excessive alcohol drinking. The "Two-Hit hypothesis" that both genetic and environmental factors contribute to excessive alcohol intake is the overarching focus of our current and proposed INIA research. Microarray results from our present UO1 funding have allowed substantial inroads to be made into the understanding of both the genetic predisposition to drink and the molecular consequences of alcohol exposure. Significant candidate genes have been identified though the overlap of several of our own studies and importantly across INIA collaborations. A large searchable, open source web-base database system containing over 30 million microarray data points from our studies was created to make sharing all data within and beyond the alcoholism research field facile (publicly announced in Bergeson et al., 2005). Our current objectives are to continue to build our array database to include expression analyses of six new INIA mouse models, focus us on characterizing candidate genes that fit our "two-hit hypothesis", and to use genetically altered mice and brain region specific viral mediated trans- gene and shRNA expression to test bi-directional expression (up and down regulation) effects on alcohol drinking. We will perform neurocirciutry specific microarray studies following viral-mediated gene changes in the presence and absence of alcohol drinking to better understand anatomical and molecular contributions to excessive alcohol drinking. Finally, initial studies focused on the role of miRNA and chromatin remodeling in alcohol drinking and/or consequences are proposed.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Effective Reduction in High Ethanol Drinking by Semisynthetic Tetracycline Derivatives.
通过半合成四环素衍生物有效降低高乙醇饮用。
DOI: 10.1111/acer.13253
发表时间: 2016-12
期刊: Alcoholism, clinical and experimental research
影响因子: --
作者: [Syapin PJ, Martinez JM, Curtis DC, Marquardt PC, Allison CL, Groot JA, Baby C, Al-Hasan YM, Segura I, Scheible MJ, Nicholson KT, Redondo JL, Trotter DRM, Edwards DS, Bergeson SE]
通讯作者: Bergeson SE
DOI: 10.1016/j.bbi.2011.03.002
发表时间: 2011-06
期刊: BRAIN BEHAVIOR AND IMMUNITY
影响因子: 15.1
作者: [Agrawal, R. G., Hewetson, A., George, C. M., Syapin, P. J., Bergeson, S. E.]
通讯作者: Bergeson, S. E.
Supplement to: Medication Development for the Treatment of Alcohol Use Disorder - U01AA028957
Medication Development for the Treatment of Alcohol Use Disorder
Medication Development for the Treatment of Alcohol Use Disorder
Neuroimmune Interactions in High Alcohol Drinking
海外基金